These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6221010)

  • 61. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 62. Antibacterial activity of six beta-lactams and six quinolones against urinary gram negative bacteria.
    Galante D; Esposito S; Barba D
    Boll Ist Sieroter Milan; 1986; 65(5):361-7. PubMed ID: 3828090
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A review of urinary tract infection in the elderly.
    Bendall MJ
    J Antimicrob Chemother; 1984 May; 13 Suppl B():69-78. PubMed ID: 6234278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The in-vitro comparative activity of quinolones against bacteria from urinary tract infections in general practice.
    Willems FT; Boerema JB; von Summeren TR
    J Antimicrob Chemother; 1986 Jan; 17(1):69-73. PubMed ID: 2936709
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Belgian multicenter in vitro study of norfloxacin.
    Verbist L
    Acta Clin Belg; 1985; 40(3):167-73. PubMed ID: 3161262
    [No Abstract]   [Full Text] [Related]  

  • 66. In vitro activity of norfloxacin against Neisseria gonorrhoeae.
    Piffaretti JC; Arini A; Peduzzi R
    Chemotherapy; 1983; 29(6):415-8. PubMed ID: 6228391
    [TBL] [Abstract][Full Text] [Related]  

  • 67. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of aztreonam against other antibiotics used in urinary tract infections.
    Khan MT; Shah SH
    J Ayub Med Coll Abbottabad; 2001; 13(4):22-4. PubMed ID: 11873424
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients.
    Panichi G; Pantosti A; Testore GP
    J Antimicrob Chemother; 1983 Jun; 11(6):589-92. PubMed ID: 6224769
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Norfloxacin--a new quinolone for urinary infection.
    J Antimicrob Chemother; 1984 May; 13 Suppl B():1-142. PubMed ID: 6234269
    [No Abstract]   [Full Text] [Related]  

  • 72. Norfloxacin for selective decontamination: a study in human volunteers.
    De Vries-Hospers HG; Welling GW; Van der Waaij D
    Prog Clin Biol Res; 1985; 181():259-62. PubMed ID: 3161087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.
    Newsom SW; Matthews J; Amphlett M; Warren RE
    J Antimicrob Chemother; 1982 Jul; 10(1):25-30. PubMed ID: 6213593
    [No Abstract]   [Full Text] [Related]  

  • 74. Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar.
    Tenney JH; Maack RW; Chippendale GR
    Antimicrob Agents Chemother; 1983 Jan; 23(1):188-9. PubMed ID: 6219620
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Norfloxacin treatment of acute cystitis in the female and bacterial prostatitis].
    Bischoff W
    Fortschr Med; 1985 Feb; 103(8):225-8. PubMed ID: 3156797
    [No Abstract]   [Full Text] [Related]  

  • 76. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Norfloxacin versus nalidixic acid in the treatment of urinary tract infections.
    Karachalios GN; Georgiopoulos AN
    Int J Clin Pharmacol Ther Toxicol; 1987 Jun; 25(6):317-9. PubMed ID: 3623736
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 79. Use of norfloxacin for prevention of symptomatic urinary tract infection in chronically catheterized patients.
    Rutschmann OT; Zwahlen A
    Eur J Clin Microbiol Infect Dis; 1995 May; 14(5):441-4. PubMed ID: 7556234
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
    Frimodt-Møller PC; Jensen KM; Madsen PO
    Antimicrob Agents Chemother; 1983 Oct; 24(4):560-3. PubMed ID: 6228191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.